| Cisplatin | Approved Investigational | ZNF200 | 7752 |
downregulated | Cisplatin results in decreased expression of ZNF200 mRNA | 16p13.3 | |
| Cisplatin | Approved Investigational | ZNF202 | 7753 |
downregulated | Cisplatin results in decreased expression of ZNF202 mRNA | 11q23.3 | |
| Cisplatin | Approved Investigational | ZNF23 | 7571 |
upregulated | Cisplatin results in increased expression of ZNF23 mRNA | 16q22.2 | |
| Cisplatin | Approved Investigational | ZNF232 | 7775 |
downregulated | Cisplatin results in decreased expression of ZNF232 mRNA | 17p13.2 | |
| Cisplatin | Approved Investigational | ZNF277 | 11179 |
upregulated | Cisplatin results in increased expression of ZNF277 mRNA | 7q31.1 | |
| Cisplatin | Approved Investigational | ZNF319 | 57567 |
upregulated | Cisplatin results in increased expression of ZNF319 mRNA | 16q21 | |
| Cisplatin | Approved Investigational | ZNF337 | 26152 |
downregulated | Cisplatin results in decreased expression of ZNF337 mRNA | 20p11.21 | |
| Cisplatin | Approved Investigational | ZNF45 | 7596 |
downregulated | Cisplatin results in decreased expression of ZNF45 mRNA | 19q13.2 | |
| Cisplatin | Approved Investigational | ZNF503 | 84858 |
upregulated | Cisplatin results in increased expression of ZNF503 mRNA | 10q22.2 | |
| Cisplatin | Approved Investigational | ZNF544 | 27300 |
downregulated | Cisplatin results in decreased expression of ZNF544 mRNA | 19q13.43 | |
| Cisplatin | Approved Investigational | ZNF561 | 93134 |
downregulated | Cisplatin results in decreased expression of ZNF561 mRNA | 19p13.2 | |
| Cisplatin | Approved Investigational | ZNF671 | 79891 |
downregulated | Cisplatin results in decreased expression of ZNF671 mRNA | 19q13.43 | |
| Cisplatin | Approved Investigational | ZNF79 | 7633 |
upregulated | Cisplatin results in increased expression of ZNF79 mRNA | 9q33.3 | |
| Cisplatin | Approved Investigational | ZNRF3 | 84133 |
downregulated | Cisplatin results in decreased expression of ZNRF3 mRNA | 22q12.1 | |
| Dichlorvos | Experimental Vet Approved | GNLY | 10578 |
downregulated | Dichlorvos results in decreased expression of GNLY mRNA | 2p11.2 | |
| Dichlorvos | Experimental Vet Approved | GZMA | 3001 |
downregulated | Dichlorvos results in decreased expression of GZMA mRNA | 5q11.2 | |
| Dichlorvos | Experimental Vet Approved | PRF1 | 5551 |
downregulated | Dichlorvos results in decreased expression of PRF1 mRNA | 10q22.1 | |
| Diclofenac | Approved Investigational Vet Approved | ABCB4 | 5244 |
downregulated | Diclofenac results in decreased expression of ABCB4 mRNA | 7q21.12 | |
| Diclofenac | Approved Investigational Vet Approved | ACKR3 | 57007 |
downregulated | Diclofenac results in decreased expression of ACKR3 mRNA | 2q37.3 | |
| Diclofenac | Approved Investigational Vet Approved | ADK | 132 |
upregulated | Diclofenac results in increased expression of ADK mRNA | 10q22.2 | |
| Diclofenac | Approved Investigational Vet Approved | ALB | 213 |
upregulated | Diclofenac results in increased expression of ALB mRNA | 4q13.3 | |
| Diclofenac | Approved Investigational Vet Approved | ASNS | 440 |
downregulated | Diclofenac results in decreased expression of ASNS mRNA | 7q21.3 | |
| Diclofenac | Approved Investigational Vet Approved | ATF4 | 468 |
upregulated | Diclofenac results in increased expression of ATF4 mRNA | 22q13.1 | |
| Diclofenac | Approved Investigational Vet Approved | BCL2A1 | 597 |
downregulated | Diclofenac results in decreased expression of BCL2A1 mRNA | 15q25.1 | |
| Diclofenac | Approved Investigational Vet Approved | BCL2L1 | 598 |
upregulated | Diclofenac results in increased expression of BCL2L1 mRNA alternative form | 20q11.21 | |